TEA Fee For Expedited Review, Dedicated Staff Increase Suggested
This article was originally published in The Rose Sheet
Executive Summary
FDA should consider establishing a voluntary fee option for expedited reviews of OTC monograph time and extent applications, Ciba Specialty Chemicals recommends in April 13 comments to the agency